tiprankstipranks
Advertisement
Advertisement
Treace Medical participates in a conference call with BTIG
PremiumThe FlyTreace Medical participates in a conference call with BTIG
3M ago
Treace Medical backs FY26 revenue view $202M-$212M, consensus $205.92M
Premium
The Fly
Treace Medical backs FY26 revenue view $202M-$212M, consensus $205.92M
3M ago
Treace Medical reports Q1 EPS (28c), consensus (31c)
Premium
The Fly
Treace Medical reports Q1 EPS (28c), consensus (31c)
3M ago
Treace Medical price target lowered to $2.25 from $2.50 at UBS
PremiumThe FlyTreace Medical price target lowered to $2.25 from $2.50 at UBS
5M ago
Treace Medical price target lowered to $7 from $7.50 at Lake Street
Premium
The Fly
Treace Medical price target lowered to $7 from $7.50 at Lake Street
5M ago
Treace Medical reports Q4 EPS (15c), consensus (15c)
Premium
The Fly
Treace Medical reports Q4 EPS (15c), consensus (15c)
5M ago
Treace Medical anticipates ‘continued positive procedure volume growth’
PremiumThe FlyTreace Medical anticipates ‘continued positive procedure volume growth’
7M ago
Treace Medical reports completion of first Lapiplasty Lightning technology case
Premium
The Fly
Treace Medical reports completion of first Lapiplasty Lightning technology case
7M ago
Treace Medical price target lowered to $3 from $5 at Stifel
Premium
The Fly
Treace Medical price target lowered to $3 from $5 at Stifel
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100